Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2021 ∙ NACI
NACI rapid response: Additional dose of COVID-19 vaccine in immunocompromised individuals following 1- or 2- dose primary series - 10 September, 2021
Recommendation Americas Canada immunocompromised COVID-19
Download:
2021 ∙ NACI
NACI rapid response: Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada
Recommendation Americas Canada dosing schedule COVID-19
Download:
2021 ∙ NACI
NACI Rapid Response: Interchangeability of Authorized COVID-19 Vaccines - 01 June 2021
Recommendation Americas Canada Interchangeability COVID-19
Download:
2021 ∙ NACI
NACI rapid response: Recommended use of AstraZeneca COVID-19 vaccine in younger adults
Recommendation Americas Canada Adults Safety AstraZeneca COVID-19 vaccine COVID-19
Download:
2021 ∙ JCVI
New COVID-19 vaccine advice for adults living with adults who are immunosuppressed
Recommendation Europe United Kingdom Risk group COVID-19
Download:
2021 ∙ NIAC
NIAC Overview of Recommendations regarding booster doses of COVID-19 Vaccine for those aged 60 to 79 years
Recommendation Europe Ireland COVID-19
Download:
2021 ∙ NIAC
NIAC Recommendations on booster doses of COVID-19 vaccine for healthcare workers, 16-59 years with underlying conditions, and all those 50-59 years
Recommendation Europe Ireland COVID-19
Download:
2021 ∙ NIAC
NIAC Recommendations on booster doses of COVID-19 vaccine for those aged 16-49 years
Recommendation Europe Ireland booster dose COVID-19
Download:
2021 ∙ NIAC
NIAC Recommendations on COVID-19 vaccination for children aged 5 to 11 Years
Recommendation Europe Ireland children COVID-19
Download:
2021 ∙ NIAC
NIAC UPDATED RECOMMENDATIONS FOR COVID-19 VACCINATION IN PREGNANCY
Recommendation Europe Ireland pregnant women COVID-19
Download:
Loading...